Rus Eng
Main / Company's news / GEROPHARM is among the TOP-30 companies of the "TechUp" rating

GEROPHARM is among the TOP-30 companies of the "TechUp" rating

16 November 2012

GEROPHARM became one of 30 rapid-growing and high-technology Russian companies according to the "TechUp" rating results. The rating was developed by the Association of Innovative Regions of Russia (AIRR) with the support of RVK JSC, “Rusnano” JSC and SME Bank. Presentation of the results and the ceremony of awarding the leading companies were held at the site of the Moscow International Forum of innovative development “Open Innovation”.

It is the first time such a detailed rating is developed in Russia. The first rating stage included making the list of TOP-100 companies, of which first 30, and then 10 rating leaders were selected. The rating involved the companies which had been established before 1987, and which focus their activity on development and commercialization of high-technology products with a stable positive dynamics of sales, sell their own products in many regions of Russia, and have an annual turnover of RUS 100 million or more.

The rating participants are selected by the expert council which was presented by successful, innovative entrepreneurs, owners and managers of large innovative companies, investors, directors of media and consulting companies offering professional promotion and support for innovative businesses and companies in Russia.

GEROPHARM is being dynamically developed and adheres to a comprehensive approach. In 2009, the company became one of the first companies to have initiated the idea of forming a pharmaceutical cluster in St. Petersburg. In late 2011, the company opened its own world-class R&D Center in SEZ “Neudorf” (St. Petersburg). In 2012, GEROPHARM became a resident of the “Northern” Biopharmaceutical Cluster in the Moscow region. “Such a high estimation given by experts confirms the success of our development strategy,” said Petr Rodionov, General Director of GEROPHARM Group.

At the same time, the company develops production sites according to the GMP Standards. In the spring of 2013 a factory in the Moscow region focusing on production of genetically engineered insulin and sterile drug products based on it will be opened. Also, the new factory will produce modern drugs for treatment of diabetes and other socially significant diseases. In addition, GEROPHARM implements a project on establishment of a manufacturing complex in the St. Petersburg pharmaceutical cluster which will produce innovative products and generic drugs, which are of higher-priority in terms of import substitution.

The rating winners were congratulated by the organizers’ representatives - Igor Agamirzyan, General Director of RVK JSC, and Ivan Bortnik, Executive Director of the Association of Innovative Regions of Russia, who said: “The companies included in our list are the rising stars of not only Russian but also the international business. I am convinced that we should talk about such companies as much as possible. Because they do what very few people are able to in Russia: it is the commercialization of knowledge.”

The awarding ceremony was also attended by distinguished guests - Alexey Komissarov, Head of the Moscow Department for Science, Industrial Policy and Entrepreneurship; Anatoly Chubais, Head of “RUSNANO”, Oleg Fomichev, Deputy Minister of Economic Development; as well as Sergey Tsyb, Director of the Department for Chemical and Technological Complex and Bioengineering Technology of the Ministry of Industry and Trade of the Russian Federation.

You are a health care professional?

Go up